A Safety and Efficacy Study of a Topical Gel for the Treatment of Mild to Moderate Psoriasis

Clinical trial NCT00593177 · COMPLETED

Trial details

NCT number: NCT00593177
Sponsor: Manhattan Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriasis Vulgaris

Start date: 2007-10-01
Primary completion: 2008-06-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.